English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Summary   Aims  The aim of this study was to investigate the quality and timing of the diagnosis and treatment of nocturia in real‐life practice in European and  US ‐American patients to obtain better insights into the management of nocturia in different Western healthcare systems.    Methods  Data were drawn from the “ LUTS  Disease Specific Programme,” a real‐life survey of physicians and patients in France, Germany, Spain,  UK  and the  USA . Physicians completed a patient record form for lower urinary tract symptoms ( LUTS ) patients. Patients filled out a self‐completion form, indicating – among other items – information on the mean number of day‐ and night‐time voids during the last 7 days, and questions on the management of  LUTS  in daily practice.    Results  In total, 8659 patients were analysed. The majority of patients initially consulted a physician because of worsening of  LUTS  frequency (43%–58%) or severity (44%–55%). Only 37% of all  LUTS  diagnoses, regardless of the appearance or severity of nocturia, were based on bladder diaries. Patients took approximately 1 year to consult a medical professional following the onset of  LUTS . At the initial visit, most patients received advice on behavioural strategies. Regardless the type of  LUTS  and physician, 59% of men received α‐blockers and 76% of women antimuscarinics.    Conclusions  Data show that patients with nocturia and  LUTS  accept their symptoms for a considerable period before they seek help or ultimately receive treatment. They may therefore be enduring significant negative impact on their quality‐of‐life which could be avoided. Physicians rarely use bladder diaries and primarily use antimuscarinics (women) or α‐blockers (men). Improved awareness of nocturia among patients and physicians could improve the management of nocturia.

international journal of clinical practice

Nocturia is often inadequately assessed, diagnosed and treated by physicians: results of an observational, real‐life practice database containing 8659 European and  US ‐American patients